Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of INT-747 in Patients With Diabetes and Presumed NAFLD
This study has been completed.
Study NCT00501592   Information provided by Intercept Pharmaceuticals
First Received: July 13, 2007   Last Updated: April 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type II
Fatty Liver
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Digestive System Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Liver Diseases
Metabolic Diseases
Interventions listed in this trial
INT-747
Sponsors listed in this trial
Intercept Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services